Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 33 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1191 Neoadjuvant phase 1b results: dose escalation of intratumoral PH-762 for cutaneous SCC, melanoma, or Merkel cell ( NCT06014086)

  • Linda Mahoney1
  • John Strasswimmer2
  • Mary C Spellman3
  1. 13Phio Pharmaceuticals Corp., King of Prussia, PA, USA
  2. 2Florida Atlantic University, Delray Beach, FL, USA
  3. 3Panclarity LLC, San Francisco, CA, USA
Open at sourcePDFDOICite

Related

  1. 147 JAK1- altered checkpoint inhibitor-resistant melanoma treated with intratumoral oncolytic viral therapy: a 2-patient case series
    Khola Khan, Daniel H Johnson
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  2. Intratumoral distribution of anisokaryosis in canine cutaneous mast cell tumors
    Christof A. Bertram, Frauke Wilm, Eda Parlak +12
    Veterinary PathologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  3. Surgical de-escalation strategies for non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a propensity score-matched analysis.
    Yulong Wang, Bengang Hui, Xin Wang +3
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Development and internal validation of machine learning models for predicting lymph node metastasis in cutaneous head and neck melanoma
    Bingyu Cheng, Jianqun Yu, Qiang Ji
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Machine learning based regulatory T cells related gene signature for predicting the clinical outcome and immunotherapy benefits in skin cutaneous melanoma
    Yuzhi Zheng, Xinnuo Chen, Zijian Wu +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{mahoney20261191,
  title = {{1191 Neoadjuvant phase 1b results: dose escalation of intratumoral PH-762 for cutaneous SCC, melanoma, or Merkel cell ( NCT06014086)}},
  author = {Linda Mahoney and John Strasswimmer and Mary C Spellman},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1191},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1191},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1191 Neoadjuvant phase 1b results: dose escalation of intratumoral PH-762 for cutaneous SCC, melanoma, or Merkel cell ( NCT06014086)
AU  - Linda Mahoney
AU  - John Strasswimmer
AU  - Mary C Spellman
PY  - 2026
DA  - 2026/11/08
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1191
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1191
SN  - 2051-1426
ER  -